| Authors: |
Vogel A; Hannover Medical School, Hannover, Germany; Toronto General Hospital, Toronto; Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: vogela@me.com., Sahai V; University of Michigan, Ann Arbor, USA., Hollebecque A; Gustave Roussy Cancer Center, Paris, France., Vaccaro GM; Providence Cancer Center, Portland, USA., Melisi D; Università degli studi di Verona, Verona, Italy., Al Rajabi RM; University of Kansas Medical Center, Kansas City., Paulson AS; Baylor University Medical Center, Dallas., Borad MJ; Mayo Clinic Cancer Center, Phoenix., Gallinson D; Morristown Memorial Hospital, Morristown., Murphy AG; Johns Hopkins University School of Medicine, Baltimore, USA., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea., Dotan E; Fox Chase Cancer Center, Philadelphia., Catenacci DV; University of Chicago Medicine, Chicago, USA., Van Cutsem E; University Hospitals Gasthuisberg, Leuven & University of Leuven, Leuven, Belgium., Lihou CF; Incyte Corporation, Wilmington, USA., Zhen H; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York; Weill Medical College at Cornell University, New York, USA; Trinity College Dublin School of Medicine, Dublin, Ireland. |
